Glutathione S-transferase M1, T1, and P1 Polymorphisms and Parkinson's Disease
- 24 December 2002
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 337 (1) , 5-8
- https://doi.org/10.1016/s0304-3940(02)01286-7
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- An Association between Idiopathic Parkinson's Disease and Polymorphisms of Phase II Detoxification Enzymes: Glutathione S-Transferase M1 and Quinone Oxidoreductase 1 and 2Biochemical and Biophysical Research Communications, 2001
- Oxidative Damage Linked to Neurodegeneration by Selective α-Synuclein Nitration in Synucleinopathy LesionsScience, 2000
- Overexpression of human α-synuclein causes dopamine neuron death in rat primary culture and immortalized mesencephalon-derived cellsBrain Research, 2000
- GSTM1 and mEPHX Polymorphisms in Parkinson's Disease and Age of OnsetBiochemical and Biophysical Research Communications, 2000
- Determination of glutathione S-transferase μ and Θ polymorphisms in neurological diseaseHuman & Experimental Toxicology, 1999
- ETIOLOGY AND PATHOGENESIS OF PARKINSON'S DISEASEAnnual Review of Neuroscience, 1999
- Simultaneous characterization of glutathione S-transferase M1 and T1 polymorphisms by polymerase chain reaction in American whites and blacksPharmacogenetics, 1996
- Oligonucleotides with fluorescent dyes at opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridization.Genome Research, 1995
- Glutathion s‐transferase (class μ) phenotype in Parkinson's diseaseMovement Disorders, 1994
- Iron and Aluminum Increase in the Substantia Nigra of Patients with Parkinson's Disease: An X‐Ray MicroanalysisJournal of Neurochemistry, 1991